GINA INTHAVONG: Open Payments
NPI 1912579301 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,889 in 156 payments from 21 companies in 2025. Trend: 2023 $2,864 · 2024 $3,520 · 2025 $2,889
Food & beverage: $2,451Education: $438
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 21 | $418 |
| OPKO Pharmaceuticals, LLC | 23 | $327 |
| Amgen Inc. | 15 | $281 |
| Travere Therapeutics, Inc. | 9 | $268 |
| Novartis Pharmaceuticals Corporation | 12 | $251 |
| Fresenius USA Marketing, Inc. | 16 | $236 |
| AstraZeneca Pharmaceuticals LP | 7 | $173 |
| Calliditas Therapeutics US Inc. | 13 | $173 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $166 |
| Otsuka America Pharmaceutical, Inc. | 5 | $131 |
Products named: ACTHAR, RAYALDEE, VELPHORO, TARPEYO, Fabhalta, Kerendia, KRYSTEXXA, LOKELMA.
Industry payments across LA — which companies pay providers there.
